Objectives: To identify the risk factors for nosocomial imipenem-resistant Acinetobacter baumannii (IRAB) infections. Methods: A prospective case-control study, set in an 1100-bed referral and tertiary-care hospital, of all patients who had nosocomial A. baumannii infections between January 1 and December 31, 2004. Only the first isolation of A. baumannii was considered. Results: IRAB was isolated from 66 (53.7%) patients and imipenem-sensitive Acinetobacter baumannii (ISAB) was isolated from 57 (46.3%) patients during the study period. The mean duration of hospital stay until A. baumannii isolation was 20.8 AE 13.6 days in IRAB infections, whereas it was 15.4 AE 9.4 days in ISAB infections. Of the patients, 65.2% with IRAB infections and 40.4% with ISAB infections were followed at the intensive care unit (ICU). Previous carbapenem use was present in 43.9% of the patients with IRAB and 12.3% of the patients with ISAB infection. In univariate analysis female sex, longer duration of hospital stay until infection, ICU stay, emergent surgical operation, total parenteral nutrition, having a central venous catheter, endotracheal tube, urinary catheter or nasogastric tube, previous antibiotic use, and previous administration of carbapenems were significant risk factors for IRAB infections ( p < 0.05). In multivariate analysis, longer duration of hospital stay until A. baumannii isolation (odds ratio (OR) 1.043; 95% confidence interval (CI) 1.003-1.084; p = 0.032), previous antibiotic use (OR 5.051; 95% CI 1.004-25.396; p = 0.049), and ICU stay (OR 3.100; 95% CI 1.398-6.873; p = 0.005) were independently associated with imipenem resistance. Conclusions: Our results suggest that the nosocomial occurrence of IRAB is strongly related to an ICU stay and duration of hospital stay, and that IRAB occurrence may be favored by the selection pressure of previously used antibiotics. #
Introduction
Acinetobacter baumannii is an important cause of nosocomial infections in many hospitals, which is difficult to both control and treat because of its prolonged environmental survival and its ability to develop resistance to multiple antimicrobial agents. 1, 2 Acinetobacter baumannii appears to have a propensity for developing antimicrobial resistance extremely rapidly. Moreover this resistance is multiple, causing serious therapeutic problems. 1 Carbapenems are usually the antibiotics of choice for treating serious infections caused by A. baumannii. However, reports of imipenemresistant A. baumannii (IRAB) strains have been rising steadily during the past few years, and these isolates are often multidrug-resistant. [3] [4] [5] [6] This emergence of IRAB has become a worldwide problem and a troublesome development that threatens the continued successful treatment of Acinetobacter infections. 1, 7 More data regarding the risk factors for IRAB infection are needed in order to prevent infection and to optimize therapy. Previous studies of risk factors for IRAB have focused on an outbreak or colonized/infected patients evaluated together. Acinetobacter baumannii is frequently encountered in Turkish hospitals, and many isolates exhibit resistance to the antimicrobials commonly used against such bacterial infections. The present study investigated the risk factors for nosocomial IRAB infections.
Methods
The hospital setting and study population A prospective case-control study was performed at Ankara Numune Education and Research Hospital (ANERH) in Turkey. ANERH is an 1100-bed referral and tertiary-care hospital. The hospital provides all major services except a pediatric department, including medical and surgical sub-specialties, and medical and surgical intensive care units (ICUs). The annual number of discharges was 55 422 in 2004.
Antibiotic policy
An antibiotic restriction policy has been in effect at ANERH since January 1999. The restriction is for orders of certain antibiotics; a prior consultation with an infectious diseases (ID) specialist is required for ceftazidime, cefepime, imipenem, meropenem, ticarcillin-clavulanate, piperacillin-tazobactam, cefoperazone-sulbactam, intravenous quinolones, intravenous aminoglycosides, vancomycin, and teicoplanin.
Case definition and collection of data
Prospective surveillance was conducted. Patients who had A. baumannii infections from January to December 2004 were included in the study. Patients from whom A. baumannii isolates had been recovered within 48 h of admission and those younger than 16 years of age were excluded.
Only one isolate from each patient was included (only the first A. baumannii-positive specimen). The clinical significance (colonization or infection) of each A. baumannii isolate and the type of infection were assessed according to CDC criteria 8, 9 by infectious diseases specialists. A urinary tract infection in a patient with an indwelling bladder catheter was diagnosed with detection of pyuria (!10 leukocytes/mm 3 ), growth of !10 5 CFU/ml bacteria (no more than two species) in urine culture, and clinical signs of infection (fever !38 8C, leukocytosis, abnormal macroscopic appearance of urine, presence of urinary nitrites). In patients assisted by mechanical ventilation, pneumonia was diagnosed when a new or progressive infiltrate or consolidation in chest X-ray in the presence of purulent tracheal secretions, supported by a growth of !10 5 CFU/ml bacteria in a quantitative culture of deep endotracheal aspirate was found. For non-ventilated patients, the diagnosis of nosocomial pneumonia was considered when they had a compatible chest X-ray and purulent sputum, with Gram stain and sputum culture documenting the presence of a pathogen microorganism. Surgical site infection was defined as the presence of purulent drainage and positive clinical findings (incision site pain, tenderness, localized swelling, redness or heat, spontaneous opening of the incision) supported by microbiologic analysis of specimens. Sepsis was diagnosed by the presence of the sepsis criteria and positive blood cultures. Patients colonized with A. baumannii were excluded.
Data were recorded on individual forms for each patient. The form included age, sex, diagnosis, date of admission to hospital and ICU, hospitalization period before ICU, length of hospital and ICU stay, transfer from another hospital, comorbidity (renal failure, hepatic failure, malignancy, immunosuppression, diabetes mellitus, chronic lung disease, malnutrition, transplantation), elective or emergent surgical operations, APACHE II (acute physiological and chronic health evaluation) score, ventilator support, physical examination findings, hematological and biochemical test results, antibiotics given to the patient, culture and antimicrobial susceptibility test results, and time between admission and isolation of the first positive A. baumannii culture.
Prior exposures to antimicrobial drugs were also explored. Prior antibiotic exposures were defined as at least 24 h of therapy during the 14 days prior to isolation of the A. baumannii.
The patients were assigned as IRAB cases (case patients) if they had imipenem-resistant A. baumannii infections and as ISAB cases (control patients) if they had imipenem-sensitive A. baumannii infections.
Microbiological examination
Identification and antimicrobial susceptibility of the Gramnegative bacteria isolated from ICU-acquired infections were performed by VITEK automated system (BioMerieux). The GNI+ panel was used for identification and GN528 panel for the detection of antimicrobial susceptibility. The isolates with a minimum inhibitory concentration (MIC) value !8 mg/ml were recorded as imipenem-resistant and those with a MIC value <8 mg/ml as imipenem-sensitive. All of the strains were tested against the following antibiotics: amikacin, gentamicin, aztreonam, ceftazidime, cefepime, imipenem, netilmicin, ciprofloxacin, pefloxacin, piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, and trimethoprim-sulfamethoxazole. Intermediately susceptible strains were accepted as resistant.
Risk factors for nosocomial IRAB infections

Statistical analysis
Potential risk factors were analyzed by univariate and multivariate analysis. Results are expressed as mean AE SD unless otherwise indicated. The Student's t-test for independent and paired continuous variables and the Chi-square test or Fisher's exact test were used when appropriate to compare proportions. A p-value of <0.05 was considered statistically significant. To test the independence of the risk factors for imipenem resistance, the significant variables ( p < 0.05) in the univariate analyses were entered into a multivariate logistic regression model with backward selection of independent variables. Risk factors were checked for confounding and co-linearity. The software package STATA 7.0 (College station, Texas, USA) was used for the analysis.
Results
During the study period, A. baumannii infections were detected in 123 patients. Mean age was 47.9 AE 19 (range 16-90) and 83 (67.5%) were male. ICU patients accounted for 66 (53.7%) of the infected patients. The most frequent infection was SSI (30.9%), followed by blood stream infection (26.8%), pneumonia (26.0%), and urinary tract infection (16.3%).
Of the 123 patients, 66 (53.7%) had IRAB and 57 (46.3%) had ISAB infections. The most frequent types of infections were pneumonia (30.3%) and SSI (28.8%) with IRAB, whereas with ISAB they were SSI (33.3%) and blood stream infection (31.6%) ( Table 1) . No statistically significant difference was found between the infection sites caused by IRAB and ISAB ( p > 0.05).
The mean duration of hospital stay until A. baumannii isolation was 20.8 AE 13.6 days in IRAB infections, whereas it was 15.4 AE 9.4 days in ISAB infections ( p = 0.014). Of the patients, 65.2% with an IRAB infection and 40.4% with an ISAB infection were followed at the ICU.
IRAB infections were seen more frequently in ICUs than wards (65.2% and 34.8%, respectively, p = 0.006). The medical or surgical services from which patients with IRAB and ISAB infections were receiving care included medical wards (26% and 29.5%, respectively) and surgical wards (73.9 and 70.5, respectively; p = 0.784).
Results of the univariate analysis of risk factors for IRAB are outlined in Table 2 . Female sex, longer duration of hospital stay until infection, ICU stay, emergent surgical operation, total parenteral nutrition, having a central venous catheter, endotracheal tube, urinary catheter, or nasogastric tube, previous antibiotic use, and previous administration of carbapenems were significant risk factors for IRAB infections ( p < 0.05).
In multivariate analysis, longer duration of hospital stay until A. baumannii isolation (odds ratio (OR) 1.043; 95% confidence interval (CI) 1.003-1.084; p = 0.032), previous antibiotic use (OR 5.051; 95% CI 1.004-25.396; p = 0.049), and ICU stay (OR 3.100; 95% CI 1.398-6.873; p = 0.005) were independently associated with imipenem resistance ( Table 3 ).
The resistance rates of IRAB isolates to the other antibiotics were frequently higher than those of ISAB isolates (Table 4 ).
There was no outbreak due to A. baumannii during the study period.
Discussion
Various studies have reported that the incidence of imipenem resistance in Acinetobacter spp is 6-8% in the USA and Canada, 10% in Latin America, and 16% in Europe. [10] [11] [12] The overall incidence of IRAB infection/colonization in Spain is quite high at 1.36 cases/1000 hospital admissions. 2 Although there are no similar published studies with which to compare the incidence of patients with IRAB infection, in this study the frequency of IRAB infections was 1.2 cases/1000 hospital admissions, and among the Acinetobacter infections imipenem resistance was observed in 53.7%. This study assessed the risk factors for the development of IRAB infections, whereas previous studies have focused on an outbreak or colonized/infected patients have been evaluated together. 2, 3, 13 A few analyses on the risk factors for the acquisition of IRAB have been published. 2, 13 These studies have limitations as colonized patients were also enrolled.
In clinical practice, Acinetobacter infections are closely associated with surgery or the use of artificial devices. Patients become infected following initial colonization. This process is influenced by various risk factors, particularly in ICUs, where multiple manipulations following surgery, as well as the use of endotracheal tubes and intravascular, ventricular or urinary catheters, can result in colonization by opportunistic bacteria such as Acinetobacter. The presence and duration of invasive procedures, as well as exposure to broad-spectrum antibiotics have been identified as risk factors for acquisition of Acinetobacter in numerous studies. 14 In this study, it was found that longer duration of hospital stay until A. baumannii isolation, ICU admission, emergent surgical operation, total parenteral nutrition, invasive procedures such as central venous catheter, endotracheal tube, urinary catheter, or nasogastric tube, previous antibiotic use, and previous administration of carbapenems were significant risk factors for IRAB infections ( p < 0.05). Multivariate analysis showed that longer duration of hospital stay until A. baumannii isolation (OR 1.043; 95% CI 1.003-1.084;
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G. Baran et al. ; p = 0.049), and ICU stay (OR 3.100; 95% CI 1.398-6.873; p = 0.005) were independently associated with imipenem resistance. The risk of IRAB infections was three times higher for patients who stayed in the ICU. The identification of an ICU stay as a risk factor is not unexpected. It has also been reported in the acquisition of IRAB in other studies. 13 A longer stay has been identified as a risk factor in previous studies similar to our results. 3, 15, 16 Antibiotic exposure remains one of the most important risk factors for the acquisition of IRAB. 15 According to our results the previous use of carbapenems was associated with imipenem resistance. The risk for imipenem resistance was five-fold higher in patients who received previous antibiotic therapy. In the study of Scerpella et al., third-generation cephalosporins were associated with the acquisition of multiresistant A. baumannii in a nosocomial outbreak. 16 del Mar Tomas et al. reported that administration of imipenem as monotherapy was a risk factor for colonization/infection with carbapenem-resistant A. baumannii in a outbreak. 3 On the other hand Smolyakov et al., found that prior aminoglycoside therapy and ICU admission were independently associated with multidrug-resistant A. baumannii acquisition. 17 Lee et al. suggested that prior exposure to imipenem or third-generation cephalosporins were risk factors for the nosocomial occurrence of IRAB. 13 Acinetobacter spp have become resistant to almost all antimicrobial agents that are currently available, including the aminoglycosides, quinolones and broad-spectrum b-lactams. Most strains are resistant to cephalosporins, while resistance to carbapenems is being reported increasingly. 18, 19 Important differences in antimicrobial susceptibility exist between A. baumannii and other species in the genus, with A. baumannii being the most resistant species. 20, 21 Among the 490 A. baumannii isolates from patients with serious infections in 37 European hospitals participating in the 1997-2000 MYSTIC program, the two carbapenems showed the greatest clinically useful activity. Susceptibilities of A. baumannii to meropenem were very high (97-100%) in 12 Imipenem resistance, which was observed in 53.7% in this study, was higher than in previous reports from Turkey; this may be due to assessing only A. baumannii strains that were responsible for nosocomial infections. IRAB is one of the most difficult pathogens to treat, because most of the patients with IRAB infections are critically ill and are subject to invasive life support measures such as endotracheal tubes, central venous catheters, and urinary catheters. Also, the isolates of IRAB are often multidrugresistant. The development of resistance to antimicrobials in A. baumannii appears to be unstoppable. 1 Twelve of the A. baumannii isolates (9.8%) were resistant to all tested antibiotics in this study. Therapy of these infections is often difficult. Sulbactam, colistin and polymyxins may be effective in such multidrug-resistant infections. 22, 23 In conclusion, our results suggest that the nosocomial occurrence of IRAB infections are strongly related to an ICU stay and duration of hospital stay, and that IRAB occurrence may be favored by the selection pressure of previously used antibiotics.
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